Home
>
US Stocks
>
Voyager Therapeutics Inc
Voyager Therapeutics Inc
VYGR

Voyager Therapeutics Inc

$4.129.75%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.31
Today Low/High
4.07 / 4.31
52 Week Low/High
$2.82 / $12.65
P/E ratio
6.18
Market Cap
$110.77M

Company Details

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager's wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases.
Organisation
Voyager Therapeutics Inc
Headquaters
Cambridge, Massachusetts, US
Employees
177
Industry
Health Technology
CEO
G. Andre Turenne

Discover more

Frequently Asked Questions

What is Voyager Therapeutics Inc share price today

Can Indians buy Voyager Therapeutics Inc shares?

How can I buy Voyager Therapeutics Inc shares from India?

Can Fractional shares of Voyager Therapeutics Inc be purchased?

What are the documents required to start investing in Voyager Therapeutics Inc stocks?

We are a SEBI registered investement advisor